Medicare's Future Spending: Obesity Drugs Projected to Cost $35 Billion by 2034

In a significant healthcare development, it has been projected that Medicare will incur expenses exceeding $35 billion for obesity drugs over the next decade. This forecast stems from the growing adoption of weight-loss medications, which have been increasingly recognized for their efficacy in combating obesity.

Continue reading